331 related articles for article (PubMed ID: 26461147)
1. Clinical Characteristics and Treatment of Langerhans Cell Histiocytosis.
Monsereenusorn C; Rodriguez-Galindo C
Hematol Oncol Clin North Am; 2015 Oct; 29(5):853-73. PubMed ID: 26461147
[TBL] [Abstract][Full Text] [Related]
2. Langerhans cell histiocytosis.
Rodriguez-Galindo C; Allen CE
Blood; 2020 Apr; 135(16):1319-1331. PubMed ID: 32106306
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and treatment of Langerhans cell histiocytosis.
Rodriguez-Galindo C
Acta Paediatr; 2021 Nov; 110(11):2892-2902. PubMed ID: 34192374
[TBL] [Abstract][Full Text] [Related]
4. [Adult Langerhans cell histiocytosis].
de Menthon M; Meignin V; Mahr A; Tazi A
Presse Med; 2017 Jan; 46(1):55-69. PubMed ID: 27816338
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary Langerhans' cell histiocytosis.
Vassallo R; Ryu JH
Clin Chest Med; 2004 Sep; 25(3):561-71, vii. PubMed ID: 15331192
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in Langerhans cell histiocytosis.
Morimoto A; Oh Y; Shioda Y; Kudo K; Imamura T
Pediatr Int; 2014 Aug; 56(4):451-61. PubMed ID: 24840547
[TBL] [Abstract][Full Text] [Related]
7. [Langerhans-cell histiocytosis (histiocytosis X) in children].
Carstensen H; Ornvold K
Ugeskr Laeger; 1993 Jun; 155(23):1779-83. PubMed ID: 8317026
[TBL] [Abstract][Full Text] [Related]
8. Pediatric Langerhans cell histiocytosis: state of the science and future directions.
Thacker NH; Abla O
Clin Adv Hematol Oncol; 2019 Feb; 17(2):122-131. PubMed ID: 30845115
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics and treatment outcome of Langerhans cell histiocytosis: 22 years' experience of 154 patients at a single center.
Lee JW; Shin HY; Kang HJ; Kim H; Park JD; Park KD; Kim HS; Park SH; Wang KC; Ahn HS
Pediatr Hematol Oncol; 2014 Apr; 31(3):293-302. PubMed ID: 24397251
[TBL] [Abstract][Full Text] [Related]
10. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group.
Minkov M; Grois N; Heitger A; Pötschger U; Westermeier T; Gadner H
Klin Padiatr; 2000; 212(4):139-44. PubMed ID: 10994540
[TBL] [Abstract][Full Text] [Related]
11. Clinical and prognostic features of Langerhans cell histiocytosis in adults.
Sato A; Kobayashi M; Yusa N; Ogawa M; Shimizu E; Kawamata T; Yokoyama K; Ota Y; Ichinohe T; Ohno H; Mori Y; Sakaida E; Kondo T; Imoto S; Nannya Y; Mitani K; Tojo A
Cancer Sci; 2023 Sep; 114(9):3687-3697. PubMed ID: 37364599
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the BRAFV600E mutation in 19 cases of Langerhans cell histiocytosis in Japan.
Sasaki Y; Guo Y; Arakawa F; Miyoshi H; Yoshida N; Koga Y; Nakashima K; Kurita D; Niino D; Seto M; Ohshima K
Hematol Oncol; 2017 Sep; 35(3):329-334. PubMed ID: 27041734
[TBL] [Abstract][Full Text] [Related]
13. Clinical Analysis of 122 Cases of Langerhans Cell Histiocytosis.
Wang T; Su B; Han D; Tong A; Li J; Liu Y; Jin H; Fang K
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Apr; 39(2):206-210. PubMed ID: 28483018
[TBL] [Abstract][Full Text] [Related]
14. [Langerhans cell histiocytosis in adults].
Néel A; Artifoni M; Donadieu J; Lorillon G; Hamidou M; Tazi A
Rev Med Interne; 2015 Oct; 36(10):658-67. PubMed ID: 26150351
[TBL] [Abstract][Full Text] [Related]
15. Langerhans cell histiocytosis in children less than 2 years of age.
Kusuma Kumary P; Priyakumari T; Chellam VG; James FV; Nair MK
Indian Pediatr; 1999 Jan; 36(1):29-36. PubMed ID: 10709120
[TBL] [Abstract][Full Text] [Related]
16. Langerhans cell histiocytosis: an update.
Mataix J; Betlloch I
G Ital Dermatol Venereol; 2009 Apr; 144(2):119-34. PubMed ID: 19357620
[TBL] [Abstract][Full Text] [Related]
17. Langerhans cell histiocytosis: a review of past, current and future therapies.
Allen CE; McClain KL
Drugs Today (Barc); 2007 Sep; 43(9):627-43. PubMed ID: 17940639
[TBL] [Abstract][Full Text] [Related]
18. Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30-year nationwide cohort of 1478 patients under 18 years of age.
Rigaud C; Barkaoui MA; Thomas C; Bertrand Y; Lambilliotte A; Miron J; Aladjidi N; Plat G; Jeziorski E; Galambrun C; Mansuy L; Lutz P; Deville A; Armari-Alla C; Reguerre Y; Fraitag S; Coulomb A; Gandemer V; Leboulanger N; Moshous D; Hoang-Xuan K; Tazi A; Heritier S; Emile JF; Donadieu J
Br J Haematol; 2016 Sep; 174(6):887-98. PubMed ID: 27273725
[TBL] [Abstract][Full Text] [Related]
19. Langerhans cell histiocytosis in neonates.
Minkov M; Prosch H; Steiner M; Grois N; Pötschger U; Kaatsch P; Janka-Schaub G; Gadner H
Pediatr Blood Cancer; 2005 Nov; 45(6):802-7. PubMed ID: 15770639
[TBL] [Abstract][Full Text] [Related]
20. Reactivation and risk of sequelae in Langerhans cell histiocytosis.
Pollono D; Rey G; Latella A; Rosso D; Chantada G; Braier J
Pediatr Blood Cancer; 2007 Jun; 48(7):696-9. PubMed ID: 17252574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
